Loading company
Medpace Holdings, Inc.
MEDP · Nasdaq · ·
Next earnings: October 21, 2026 · after the close
$622.09+1.0%Sep 29 close
- 1M
- +3.6%
- 6M
- +35.1%
- 1Y
- +21.0%
- 5Y
- +225.7%
MEDP · Nasdaq · ·
Next earnings: October 21, 2026 · after the close
$622.09+1.0%Sep 29 close
Medpace Holdings, Inc. is scheduled to report next on October 21, 2026, after the close. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $707.3M | $603.3M | +17.24% |
| Profit | $121.4M | $90.3M | +34.46% |
| Profit per share | $4.25 | $3.10 | +37.10% |
| Free Cash Flow | $138.1M | $142.4M | -3.03% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Releases land after the close or before the open, so the move is the session that follows.
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 6,500 people across 46 countries as of June 30, 2026.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Medpace Holdings, Inc.’s Item 2.02 8-K filed July 22, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Medpace Holdings, Inc. has no earnings call transcript available.